Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,732 across all filing types
Latest filing 2022-11-10 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
111年第3季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement with detailed financial data for the third quarter and nine months of the fiscal year 111 (Taiwan calendar year), including revenue, costs, expenses, net profit, and earnings per share. The presence of actual financial figures and the coverage of a quarterly period indicate this is a substantive financial report for a period shorter than a full fiscal year. The document length is 3707 characters, which is sufficient to contain financial data but not overly brief. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2022
2022-11-10 Chinese
111年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items with amounts and percentages. The data is presented for the third quarter of the year 111 (Taiwan calendar, corresponding to 2022) and prior periods. The presence of actual financial statements with substantive financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 4369 characters, which is sufficient to contain actual financial data rather than just an announcement. There is no indication that this is an annual report, audit report, or other types of filings. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q3 2022
2022-11-10 Chinese
本公司將召開線上法人說明會
Investor Presentation Classification · 90% confidence The document is a short announcement (722 characters) about the company 1795 美時 holding an online investor conference call (法人說明會) on a specific date and time. It provides details about the event, including links and times for Chinese and English sessions. There is no actual financial data or detailed report content included, only an invitation and description of the event. According to the classification rules, this type of document is an Investor Presentation (IP) announcement or invitation, but since it is just the announcement of the event and not the presentation itself, it fits best under Investor Presentation (IP) category as it focuses on financial and operational status explanation to investors. Confidence is high due to clear keywords like '法人說明會' (investor conference) and the nature of the content.
2022-11-10 Chinese
公告本公司法務副總經理任命案
Board/Management Information Classification · 100% confidence The document is a company announcement regarding the appointment of a new Vice President of Legal Affairs. It details personnel changes, including the name, position, and effective date of the new appointee. There is no financial data, no mention of financial results, reports, or regulatory filings beyond the personnel change. This fits the category of Board/Management Information, which covers announcements of changes in senior management.
2022-11-10 Chinese
公告本公司營運暨供應鏈管理副總經理異動案
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in senior management, specifically the retirement of the Vice President of Operations and Supply Chain Management. It includes details such as the names of the outgoing and incoming individuals, their titles, and effective dates. There is no financial data, report, or presentation content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-11-10 Chinese
公告本公司公司治理主管異動
Board/Management Information Classification · 100% confidence The document is a short announcement (725 characters) about a change in the company's governance personnel, specifically the company governance supervisor. It details the old and new persons in the role, the date of change, and the reason for the change. There is no financial data, no report attached or referenced, and it clearly relates to management or board changes. According to the definitions, this fits the category of Board/Management Information (MANG).
2022-11-10 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.